Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses-Reference-Cited by-同舟云学术

Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses

Published:2023-03 Issue: Volume:250 Page:115186
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Brier Lucile,Hassan Haitham,Hanoulle Xavier,Landry Valerie,Moschidi Danai,Desmarets Lowiese,Rouillé Yves,Dumont Julie,Herledan Adrien,Warenghem Sandrine,Piveteau Catherine,Carré Paul,Ikherbane Sarah,Cantrelle François-Xavier,Dupré Elian,Dubuisson Jean,Belouzard Sandrine,Leroux Florence,Deprez Benoit^ORCID,Charton Julie^ORCID

Funder

ERC

ERDF

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference37 articles.

1. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, people's Republic of China, in February, 2003;Zhong;Lancet,2003

2. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia;Zaki;N. Engl. J. Med.,2012

3. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N. Engl. J. Med.,2020

4. Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);Shitrit;Sci. Rep.,2020

5. Comprehensive insights into the catalytic mechanism of Middle East respiratory syndrome 3C-like protease and severe acute respiratory syndrome 3C-like protease;Wang;ACS Catal.,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11

2. N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL protease;European Journal of Medicinal Chemistry;2024-10

3. Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A review;Bioorganic Chemistry;2024-06

4. Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics;ACTA PHARM SIN B;2024

5. Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics;Acta Pharmaceutica Sinica B;2024-05